产品简要
公司名称 :
武汉三鹰
产品类型 :
抗体
产品名称 :
HER2/v-erb-b2成红细胞白血病病毒致瘤基因2
目录 :
18299-1-AP
规格 :
150UL
价格 :
299美元
克隆性 :
多克隆
宿主 :
domestic rabbit
共轭标签 :
未共轭
反应物种 :
人类
应用 :
免疫印迹, 酶联免疫吸附测定, 免疫组化, 免疫细胞化学, 免疫沉淀, 流式细胞仪
更多信息或购买 :
文章摘录数: 19
参考文献
Lin L, Luo X, Wang L, Xu F, He Y, Wang Q, et al. BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway. Int Immunopharmacol. 2020;85:106625 pubmed 出版商
Yang Z, Yang L, Xu C, Wang X, Lei L. An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway. Biol Open. 2020;9: pubmed 出版商
Mei Y, Cai D, Dai X. Modulating cancer stemness provides luminal a breast cancer cells with HER2 positive-like features. J Cancer. 2020;11:1162-1169 pubmed 出版商
Xiang R, Han X, Ding K, Wu Z. CMIP promotes Herceptin resistance of HER2 positive gastric cancer cells. Pathol Res Pract. 2020;216:152776 pubmed 出版商
Liu R, Shuai Y, Luo J, Zhang Z. SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis. Front Oncol. 2019;9:1035 pubmed 出版商
Wang D, Hu X, Liu C, Jia Y, Bai Y, Cai C, et al. Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers. Cell Res. 2019;29:832-845 pubmed 出版商
Dai X, Cheng H, Chen X, Li T, Zhang J, Jin G, et al. FOXA1 is Prognostic of Triple Negative Breast Cancers by Transcriptionally Suppressing SOD2 and IL6. Int J Biol Sci. 2019;15:1030-1041 pubmed 出版商
Zheng X, Chen Y, Bai M, Liu Y, Xu B, Sun R, et al. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen. Free Radic Biol Med. 2019;131:7-17 pubmed 出版商
Liu Y, Xu J, Choi H, Han C, Fang Y, Li Y, et al. Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer. Nat Commun. 2018;9:4718 pubmed 出版商
Namba M, Hattori N, Hamada H, Yamaguchi K, Okamoto Y, Nakashima T, et al. Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1. Cancer Lett. 2018;442:31-39 pubmed 出版商
Wang D, Liu C, Wang J, Jia Y, Hu X, Jiang H, et al. Protein C receptor stimulates multiple signaling pathways in breast cancer cells. J Biol Chem. 2018;293:1413-1424 pubmed 出版商
Li Y, Li L, Zhang G, Wang Y, Chen H, Kong R, et al. Crucial microRNAs and genes in metformin's anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysis. Invest New Drugs. 2018;36:20-27 pubmed 出版商
Tan S, Ding K, Chong Q, Zhao J, Liu Y, Shao Y, et al. Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells. J Biol Chem. 2017;292:13551-13564 pubmed 出版商
Li G, Zheng J, Xu B, Ling J, Qiu W, Wang Y. Simvastatin inhibits tumor angiogenesis in HER2-overexpressing human colorectal cancer. Biomed Pharmacother. 2017;85:418-424 pubmed 出版商
Zhang W, Li Y, Wei M, Chen Y, Qiu J, Jiang Q, et al. Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer. Cancer Lett. 2017;386:100-109 pubmed 出版商
Sakata K, Araki K, Nakano H, Nishina T, Komazawa Sakon S, Murai S, et al. Novel method to rescue a lethal phenotype through integration of target gene onto the X-chromosome. Sci Rep. 2016;6:37200 pubmed 出版商
Zhang Z, Li H, Zhou C, Li Q, Ma L, Zhang Z, et al. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells. J Exp Clin Cancer Res. 2016;35:149 pubmed
Lu Y, Wang Y, Zhang M, Liu L, Li F, Zhang J, et al. HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth. Oncotarget. 2016;7:23594-607 pubmed 出版商
Maranto C, Perconti G, Contino F, Rubino P, Feo S, Giallongo A. Cellular stress induces cap-independent alpha-enolase/MBP-1 translation. FEBS Lett. 2015;589:2110-6 pubmed 出版商
图像
图像 1 :
武汉三鹰 18299-1-AP 图像 1
The HER2/ErbB2 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human HER2/ErbB2. This antibody recognizes human antigen. The HER2/ErbB2 antibody has been validated for the following applications: FC, IF, IHC, IP, WB, ELISA analysis.
产品信息
目录号 :
18299-1-AP
AntigenName :
HER2/v-erb-b2成红细胞白血病病毒致瘤基因2
Package :
150UL
价格 :
299美元
Exsists20ul :
20ul trial size available
FullName :
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
免疫原 :
多肽
物种 :
人类, 小鼠
宿主 :
IsConjugated :
未共轭
AntigenSpecies :
人类
应用 :
免疫印迹, 免疫沉淀, 免疫组化, IF, FC, 酶联免疫吸附测定
Clonlity :
多克隆
抗体亚型 :
IgG
同义词 :
CD340, ERBB2, HER 2, HER 2/neu, HER2, MLN 19, MLN19, NEU, NGL, p185, p185erbB2, Proto oncogene c ErbB 2, Proto oncogene Neu, TKR1
PrimaryOrSecondary :
Primary
抗体缓冲液 :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
GenBank登录号 :
BC167147
类别 :
Binding Proteins;Cell Cycle;Cytoskeleton/Scaffold Proteins;Development;Disease Related;IVD;Membrane Proteins;Metabolism;Oncogene(s) and Tumor Suppressor(s);Signal transduction;
PurifyMethod :
抗原亲和纯化
NewAb :
False
IsSellable :
True
AppTiter :
FC 1:0;IF 1:50;免疫组化1:600;免疫沉淀1:500;免疫印迹1:2000;
更多信息或购买 :
公司信息
武汉三鹰
武汉市洪山区关山二路关东科技园7-4#,402室
Service@ptglab.com
http://www.ptgcn.com
4006 900 926, 027-87531629 / 027-87531627
公司总部: 美国
Proteintech Group致力于开发针对所有人类蛋白的抗体,我们将这项计划命名为人类抗体组计划。Proteintech Group在科研领域享有良好声誉, 迄今已生产出针对10,000种不同人类蛋白的10,000种抗体。同时,Proteintech Group也提供多种客户订单服务:克隆,表达,多肽合成,多抗及单抗生产,以满足您的不同需求。

Proteintech Group的创建者都是资深科研人员,我们非常理解科学家们对工作尽善尽美的追求,我们也以同样的标准来要求我们的产品。作为科研领域的成员之一,我们要做每一项科研工作背后的默默支持者,为科学家们提供质量优良,价格合理的产品和服务。

我们承诺为您提供高品质的抗体及相关产品,让您不再担忧试剂的品质,让您能够倾注您全部的创造力,才华和精力于研究当中。我们坚信只有您成功了,我们才会成功。